McGinnis J F, de Vellis J
Proc Natl Acad Sci U S A. 1981 Feb;78(2):1288-92. doi: 10.1073/pnas.78.2.1288.
The concentration of glycerol-3-phosphate dehydrogenase (GPDH; sn-glycerol-3-phosphate:NAD(+) 2-oxidoreductase, EC 1.1.1.8) had previously been determined to be regulated by glucocorticoids in rat brain cells in vivo and in cell culture. We now demonstrate that concanavalin A (Con A) can inhibit the induction of GPDH in dose-dependent manner in C6 rat glioma cells and in primary cultures of rat brain oligodendrocytes. Con A is not cytotoxic, because its effect can be prevented or reversed by alpha-methyl mannoside. The inhibition specifically prevents the appearance of new molecules of GPDH, although Con A does not significantly inhibit protein synthesis in these cells, nor does it affect the activity of another soluble enzyme, lactate dehydrogenase. The ability to block enzyme induction is not limited to Con A, because other lectins also inhibit induction, with Ricinus communis agglutinin 60 being the most potent (50% inhibition of induction at 0.0083 muM) and wheat germ agglutinin being the least potent (50% inhibition of induction at 1.2 muM). The molecular mechanism by which Con A inhibits GPDH induction appears to be by the "down regulation" of the cytoplasmic glucocorticoid receptors, because exposure to Con A results in the loss of more than 90% of the receptor activity. Con A does not inhibit the receptor assay and no direct interaction between the receptor and Con A could be demonstrated. This down regulation is not tumor cell specific and appears to be a general phenomenon, because it occurs in normal oligodendrocytes and even in normal astrocytes (a cell type in which the gene for GPDH is not expressed). The down regulation of glucocorticoid receptors in normal brain cells suggests two important corollaries. First, it demonstrates the existence of a rate-limiting step controlling the glucocorticoid-dependent gene expression in brain cells and possibly represents a regulatory site common to all glucocorticoid target cells. Second, it suggests that the response to glucocorticoids of oligodendrocytes and astrocytes can be regulated in vivo by cell surface contact with endogenous lectins, neighboring cells, or both.
此前已确定,甘油-3-磷酸脱氢酶(GPDH;sn-甘油-3-磷酸:NAD(+) 2-氧化还原酶,EC 1.1.1.8)的浓度在体内大鼠脑细胞和细胞培养中受糖皮质激素调节。我们现在证明,伴刀豆球蛋白A(Con A)能以剂量依赖的方式抑制C6大鼠胶质瘤细胞和大鼠脑少突胶质细胞原代培养物中GPDH的诱导。Con A没有细胞毒性,因为其作用可被α-甲基甘露糖苷阻止或逆转。这种抑制特异性地阻止了新的GPDH分子的出现,尽管Con A在这些细胞中不会显著抑制蛋白质合成,也不影响另一种可溶性酶乳酸脱氢酶的活性。阻断酶诱导的能力并不局限于Con A,因为其他凝集素也能抑制诱导,其中蓖麻凝集素60最有效(在0.0083 μM时对诱导的抑制率为50%),而麦胚凝集素最无效(在1.2 μM时对诱导的抑制率为50%)。Con A抑制GPDH诱导的分子机制似乎是通过细胞质糖皮质激素受体的“下调”,因为暴露于Con A会导致超过90%的受体活性丧失。Con A不抑制受体测定,且未证明受体与Con A之间有直接相互作用。这种下调不是肿瘤细胞特有的,似乎是一种普遍现象,因为它发生在正常少突胶质细胞甚至正常星形胶质细胞(一种不表达GPDH基因的细胞类型)中。正常脑细胞中糖皮质激素受体的下调提示了两个重要的推论。首先,它证明了存在一个控制脑细胞中糖皮质激素依赖性基因表达的限速步骤,并且可能代表了所有糖皮质激素靶细胞共有的一个调节位点。其次,它表明少突胶质细胞和星形胶质细胞对糖皮质激素的反应在体内可通过与内源性凝集素、相邻细胞或两者的细胞表面接触来调节。